3fuller GN, Jaeobs JM, Guiloff RJ. Subclinical peripheral nerve involvement in AIDS: an eleetrophysiologieal and pathologieal study [ J ] .J Neurol Neurosurg Psyehiatry, 1991,54(4) :318 - 324.
4French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy[J ]. AIDS,2004,18(12) : 1615 - 1628.
5French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy[J] .HIV Med,2000,1(2) : 107 - 115.
二级参考文献13
1Janeway Charles A,Travers Paul,Walport Mark,et al. Immunobiology[ M ]. 5th ed. New York and London:Garland Publishing; 2001,455 456.
2fuller GN,Jacobs JM, Guiloff RJ. Subclinical peripheral nerve involvement in AIDS: an electrophysiological and pathological study [J ] .J Neurol Neurosurg Psychiatry, 1991,54(4) :318- 324.
3Tubiana R, Carcelain G, Mohand HA, et al. Immunologic reconstruction after antiretroviral treatment[ J ] . Presse Med, 1999,27; 28 ( 8 ):424-430.
4Zell SC. Clinical vignette in antiretroviral therapy: jaundice [ J ]. J Int Assoc Physicians AIDS Care(Chic Ⅲ) ,2003,2(4) :133-140.
5French MA,Price P,Stone SF.Immune restoration disease after antiretroviral therapy.AIDS,2004,18(12):1615-1628.
6Jevtovic DJ,Salemovic D,Ranin J,et al.The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.HIV Medicine,2005,6(2):140-143.
7Bernard EJ.Herpes and genital warts most common symptoms of IRIS.Aidsmap,2003.
8Smart T.IRIS observed in almost a third of advanced patients beginning antiretroviral therapy in Texan study.Aidsmap,2005.
9Sungkanuparph S,Vibhagool A,Mootsikapun P,et al.Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevelance of tuberculosis.AIDS,2003,17(14):2129-2131.
10French MA,Lenzo N,John M,et al.Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.HIV Med,2000,1(2):107-115.
